Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by Hopeforthebeston Jun 07, 2024 11:45am
105 Views
Post# 36077704

Proph what happened

Proph what happenedProph after all the garbage postings and defending of gagnon and NoShowRonnie you has finally moved from the dark side to see the light as you wrote:

AEZS has fallen from ~C$14 to ~C$10 as the warrants are converted. Now how many of the people who pushed the stock up to get the warrants may sell the warrants or maybe all of it. CZO's last financials were also underwhelming.This company is still a mystery too. 

AEZS is still every much a mystery until we see a plan, data, and key events. People are worried about the burn rate and how quickly cash will run out. Will it run out before AEZS can hit material valuation catalysts and will it be forces to dilute again? We need a solid plan. The diagnostic data is due in Q3 and then we could see a deal. How much cash? We've never seen any preclinical data for the avenanthramide pill. It might not be for some time that we see the first safety/tolerability, and preliminary efficacy data and have a better basis for speculation. There's data ahead of AEZS's pipeline programs and talks with regulators concerning the path forward. How much work to do before this gets to human trials and proving itself in humans? Do we have the cash? PGX hasn't cleared the 50L hurdle and then needs to clear the 100L. Let's hope it goes smoothly. A licensing deal can also be key validation.  

gagnon and now NoShow Roonie have built a house of cards where these 2 and a few of their selected friends have profitted $$$$$$ considerably while shareholders have be left holding the bag of coal. promise after promise after promise and yet to deliver meanwhile their banks have swelled by millions $$$$, hey remember how gagnon pulled back from Aezs then charged them a just shy $$$$ million $$$ consulting fee. How about running juvenite into the ground (last year sales $30,000) while makes thousands as a CEO. gagnon has proven that he is not a capable scientist or a business man or a manager. He has not able to deliver on anything yet, hell his biggest customer is now his biggest competitor but he signed a new deal anyways. The only thing he and NoShowRonnie are capable are burning through millions$$$$ every quarter ensure the demise of anything they touch.


<< Previous
Bullboard Posts
Next >>